4.0 Article

Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients With Metabolic Syndrome

Journal

CANADIAN JOURNAL OF DIABETES
Volume 45, Issue 7, Pages 614-618

Publisher

ELSEVIER
DOI: 10.1016/j.jcjd.2020.12.005

Keywords

metabolic syndrome; microRNAs; miR-21-5p; miR-148a-5p

Ask authors/readers for more resources

The study revealed that the expression of miR-148a-5p and miR-21-5p was significantly upregulated in patients with Metabolic Syndrome, indicating their potential as novel biomarkers for the diagnosis and prognosis of MetS.
Background: Metabolic syndrome (MetS) is a group of abnormalities related to metabolism that increase the risk of cardiac diseases, type 2 diabetes and mortality. MicroRNAs (miRs) act as regulators of many cellular and metabolic events, and any dysregulation of these tiny molecules can cause great disturbance in one's health. The main purpose of this study was to ascertain the diagnostic potential of miR-148a-5p and miR-21-5p in MetS. Methods: Serum levels of miR-148a-5p and miR-21-5p were quantified in 118 male patients with MetS and 30 healthy controls by quantitative real-time polymerase chain reaction. Fasting plasma glucose, serum high-density lipoprotein cholesterol and serum triacylglycerol were measured by the colorimetric method. Blood pressure and anthropometric measurements were performed on each individual. All MetS patients had diabetes and had a large waist circumference, and were divided into 3 groups: group 1, dyslipidemic and hypertensive; group 2, normotensive; and group 3, normal lipid profile. Results: miR-148a-5p expression was significantly upregulated in all MetS patients: group 1, 70.3 +/- 8.07 (p<0.0001); group 2, 75.0 +/- 9.17 (p<0.0001) and group 3, 33.7 +/- 6.89 (p<0.0001), when compared with control subjects. However, miR-21-5p expression was elevated only in the sera of group 1 (36.9 +/- 8.39, p<0.0001) and group 3 (48.9 +/- 12.0, p<0.0001), when compared with controls. Conclusions: Serum levels of miR-148a-5p and miR-21-5p were higher in MetS patients than in healthy controls; consequently, these serum miRs can serve as novel biomarkers for diagnosis and prognosis of MetS. (c) 2021 Canadian Diabetes Association.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions

Ahmed I. Abulsoud, Hussein M. El-Husseiny, Ahmed A. El-Husseiny, Hesham A. El-Mahdy, Ahmed Ismail, Samy Y. Elkhawaga, Emad Gamil Khidr, Doaa Fathi, Eman A. Mady, Agnieszka Najda, Mohammad Algahtani, Abdulrahman Theyab, Khalaf F. Alsharif, Ashraf Albrakati, Roula Bayram, Mohamed M. Abdel-Daim, Ahmed S. Doghish

Summary: COVID-19 is a global pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). The development of new vaccines with innovative technologies has revolutionized the field of vaccinology. These vaccines use mRNA encoding the Spike SARS-CoV-2 protein or recombinant adenovirus vectors to introduce the Spike protein gene into cells, allowing for faster updates to combat new variants. However, effective control of these variants requires a rapid and widespread vaccination policy with sufficient vaccine doses.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Review Medicine, Research & Experimental

miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers

Ahmed S. Doghish, Ahmed Ismail, Hesham A. El-Mahdy, Samy Y. Elkhawaga, Elsayed G. E. Elsakka, Eman A. Mady, Mahmoud A. Elrebehy, Mahmoud A. F. Khalil, Hussein M. El-Husseiny

Summary: Rheumatoid arthritis (RA) is a severe autoimmune inflammation that primarily affects the joints. miRNAs, small noncoding molecules, are involved in its pathogenesis by disrupting immune balance and triggering inflammation. Additionally, miRNAs have potential applications in RA diagnosis, prognosis, and treatment.

LIFE SCIENCES (2023)

Article Medicine, Research & Experimental

miRNAs as cornerstones in adipogenesis and obesity

Samy Y. Elkhawaga, Ahmed Ismail, Elsayed G. E. Elsakka, Ahmed S. Doghish, Mohamed A. Elkady, Hesham A. El-Mahdy

Summary: In recent decades, obesity has become a pandemic issue with significant impact on quality of life and life expectancy due to its association with serious co-morbidities. Obesity is influenced by various factors including age, sex, endocrine and genetic factors. MiRNAs, as genetic factors, have recently emerged as important regulators of obesity. MiRNAs are small noncoding nucleic acids that can modulate gene expression and affect biological processes relevant to obesity, such as adipogenesis, lipid metabolism and homeostasis. This review provides an updated overview of the roles of miRNAs in obesity and its processes and highlights their potential applications as therapeutic targets for obesity.

LIFE SCIENCES (2023)

Review Endocrinology & Metabolism

miRNAs as cornerstones in diabetic microvascular complications

Ahmed Ismail, Hesham A. El-Mahdy, Mahmoud Gomaa Eldeib, Ahmed S. Doghish

Summary: Diabetes mellitus is often accompanied by microvascular complications such as nephropathy, retinopathy, and neuropathy. MicroRNAs (miRNAs) play a crucial role in the pathogenesis of these complications by affecting the kidney, retina, and peripheral neurons through various molecular pathways. This review provides an updated understanding of the involvement of miRNAs in diabetic microvascular complications, with a focus on the key molecular pathways mediating the adverse effects of hyperglycemia on vascular tissues. The review highlights specific miRNAs (miR-126, miR-29b, miR-125a, and miR-146a) and their impact on vascular endothelial growth factors.

MOLECULAR GENETICS AND METABOLISM (2023)

Article Medicine, Research & Experimental

Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats

Shady Allam, Elsayed G. E. Elsakka, Ahmed Ismail, Ahmed S. Doghish, Amr Mohamed Yehia, Mohamed A. Elkady, Hamada Ahmed Mokhlis, Sara M. Sayed, Adel I. Abd Elaziz, Abdullah A. Hashish, Mona M. Amin, Rehab Mohamed El Shahat, Osama A. Mohammed

Summary: This study aimed to investigate the effect of flutamide, an androgen receptor (AR) blocker, on renal pathologic changes such as inflammation, apoptosis, and fibrosis in male rats. The study found that AR blockade resulted in the down-regulation of markers associated with renal inflammation, apoptosis, and fibrosis. Additionally, it was found that the blockade increased the expression of chloride channel protein-5 (ClC-5) and pAKT proteins. This research suggests that AR blockade may be an effective strategy for mitigating renal side effects caused by certain drugs.

LIFE SCIENCES (2023)

Review Medicine, Research & Experimental

An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer

Doaa Fathi, Mohammed S. Elballal, Ahmed E. Elesawy, Ahmed I. Abulsoud, Ahmed Elshafei, Elsayed G. E. Elsakka, Ahmed Ismail, Hesham A. El-Mahdy, Mahmoud A. Elrebehy, Ahmed S. Doghish

Summary: Gastric cancer (GC) ranks fourth globally in terms of incidence and mortality rates. MicroRNAs (miRNAs), among other genetic and epigenetic factors, have been found to impact the initiation and progression of GC. Dysregulation of miRNA expressions is associated with various aspects of GC, including initiation, invasion, apoptosis evasion, angiogenesis, promotion, and epithelial-mesenchymal transition enhancement. Important pathways controlled by miRNAs in GC include Wnt/8-catenin signaling, HMGA2/mTOR/P-gp pathway, PI3K/AKT/c-Myc pathway, VEGFR, and TGFb signaling. Hence, this review aims to provide an updated understanding of the role of miRNAs in GC pathogenesis and their modulatory effects on different GC treatment modalities.

LIFE SCIENCES (2023)

Article Pathology

Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications

Ola Elazazy, Heba M. Midan, Reem K. Shahin, Ahmed E. Elesawy, Mohammed S. Elballal, Al-Aliaa M. Sallam, Abdullah M. M. Elbadry, Mahmoud A. Elrebehy, Abdelmenem Bhnsawy, Ahmed S. Doghish

Summary: Long non-coding RNAs (lncRNAs), with a length larger than 200 nucleotides, play a role in controlling gene expression and have been found to be abnormally expressed in rheumatoid arthritis (RA) patients. These lncRNAs have potential as biomarkers and treatment targets for diagnosing and treating RA. This review focuses on the pathogenesis of RA, clinical implications, and related lncRNA expressions for the identification of new biomarkers and treatment targets.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Review Pathology

Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways

Ahmed S. Doghish, Hesham A. El-Mahdy, Ahmed Ismail, Maghawry Hegazy, Mahmoud Mohamed Mokhtar, Samy Y. Elkhawaga, Mohamed A. Elkady, Amr Mohamed Yehia, Elsayed G. E. Elsakka

Summary: Thyroid cancer is the most common endocrine malignant tumor, with various types such as papillary thyroid cancer and follicular thyroid carcinoma. Risk factors for thyroid cancer include radiation exposure, autoimmunity, and genetics. MicroRNA plays a crucial role in thyroid cancer by inhibiting the expression of multiple target genes and influencing tumor proliferation, angiogenesis, apoptosis, development, and resistance to therapy.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Pathology

A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance

Ahmed S. Doghish, Maghawry Hegazy, Ahmed Ismail, Hesham A. El-Mahdy, Elsayed G. E. Elsakka, Samy Y. Elkhawaga, Mohamed A. Elkady, Amr Mohamed Yehia, Nourhan M. Abdelmaksoud, Mahmoud Mohamed Mokhtar

Summary: Osteosarcoma (OS) is a common bone cancer in children, teenagers, and young adults, and various epigenetic elements, including miRNAs, have been found to affect OS progression, initiation, angiogenesis, and treatment resistance. MiRNAs can regulate the expression of genes involved in OS pathogenesis and play roles in invasion, angiogenesis, metastasis, proliferation, cell cycle, and apoptosis. MiRNAs also impact important OS-related signaling pathways, such as WNT/β-catenin, PTEN/AKT/mTOR, and KRAS mutations. Furthermore, miRNAs may influence the response of OS to therapies like radiotherapy and chemotherapy. This review focuses on the relationship between miRNAs and OS by exploring their effects on OS signaling pathways.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Review Pathology

Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review

Tohada M. Al-Noshokaty, Abdallah Mansour, Rehab Abdelhamid, Nourhan Abdellatif, Ayat Alaaeldien, Tasnim Reda, Nourhan M. Abdelmaksoud, Ahmed S. Doghish, Ahmed I. Abulsoud, Shereen Saeid Elshaer

Summary: Pancreatic cancer is a deadly cancer with poor prognosis, mainly due to the lack of reliable early detection methods. Long non-coding RNAs (LncRNAs) are protein-free RNAs produced by genome transcription and play critical roles in gene expression regulation, cell proliferation, and differentiation. Recent research has revealed that LncRNAs also play important regulatory roles in the development and progression of pancreatic cancer. This review discusses the various roles of LncRNAs in the molecular mechanisms underlying pancreatic cancer and their involvement in pathogenesis and treatment resistance.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Pathology

miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay

Shereen Saeid Elshaer, Ahmed I. Abulsoud, Doaa Fathi, Nourhan M. Abdelmaksoud, Mohamed Bakr Zaki, Hesham A. El-Mahdy, Ahmed Ismail, Elsayed G. E. Elsakka, Mai A. Abd-Elmawla, Logyna A. Abulsoud, Ahmed S. Doghish

Summary: This review summarizes the role of microRNAs (miRNAs) in the development of glioblastoma (GBM) and discusses their potential as prognostic biomarkers and therapeutic targets.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Biochemistry & Molecular Biology

Thymus Vulgaris Oil Nanoemulsion: Synthesis, Characterization, Antimicrobial and Anticancer Activities

Ahmed Doghish, Amr Shehabeldine, Hesham El-Mahdy, Mahmoud Hassanin, Abdulaziz Al-Askar, Samy Marey, Hamada Abdelgawad, Amr Hashem

Summary: In this study, a thyme essential oil nanoemulsion was successfully prepared using a safe and eco-friendly method. The nanoemulsion exhibited antibacterial, antifungal, and anticancer activities, making it a promising candidate for further research and development.

MOLECULES (2023)

Article Biochemistry & Molecular Biology

Antimicrobial, Antibiofilm, and Anticancer Activities of Syzygium aromaticum Essential Oil Nanoemulsion

Amr M. Shehabeldine, Ahmed S. Doghish, Walaa A. El-Dakroury, Mahmoud M. H. Hassanin, Abdulaziz A. Al-Askar, Hamada AbdElgawad, Amr H. Hashem

Summary: In this study, clove oil nanoemulsion (CL-nanoemulsion) and emulsion (CL-emulsion) were prepared using an ecofriendly method. The CL-nanoemulsion showed antibacterial, antifungal, anti-biofilm, and anticancer properties, with minimal inhibitory concentration (MIC) values between 0.31 and 5 mg/mL against bacteria and significant antifungal activity against various fungal strains. The CL-nanoemulsion also exhibited lower IC50 values in MCF-7 breast cancer cells compared to CL-emulsion, indicating its potential as an anticancer agent.

MOLECULES (2023)

Article Pathology

miRNAs orchestration of salivary gland cancer- Particular emphasis on diagnosis, progression, and drug resistance

Ahmed A. El-Husseiny, Nourhan M. Abdelmaksoud, Sherif S. Abdel Mageed, Aya Salman, Mohamed Bakr Zaki, Hesham A. El-Mahdy, Ahmed Ismail, Mai A. Abd-Elmawla, Hussein M. El-Husseiny, Ahmed I. Abulsoud, Shereen Saeid Elshaer, Elsayed G. E. Elsakka, Doaa Fathi, Walaa A. El-Dakroury, Ahmed S. Doghish

Summary: Salivary gland cancer is a type of head and neck cancer with poor survival rates for nonresectable tumors. Research on the pathophysiology of this cancer, particularly at the molecular level, is needed. Abnormal levels of microRNAs (miRNAs) have been found in salivary cancer tissues, suggesting their crucial role in the carcinogenesis of this cancer. Several studies have also identified potential miRNA biomarkers and therapeutic targets for salivary gland cancer. This review aims to explore the regulatory impact of miRNAs on the molecular pathology of this cancer and provide an up-to-date summary of relevant literature.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Review Pathology

Decoding the role of miRNAs in multiple myeloma pathogenesis: A focus on signaling pathways

Amr Mohamed Yehia, Elsayed G. E. Elsakka, Ahmed I. Abulsoud, Nourhan M. Abdelmaksoud, Ahmed Elshafei, Samy Y. Elkhawaga, Ahmed Ismail, Mahmoud Mohamed Mokhtar, Hesham A. El-Mahdy, Maghawry Hegazy, Mohammed S. Elballal, Osama A. Mohammed, Hussein M. El-Husseiny, Heba M. Midan, Walaa A. El-Dakroury, Moataz B. Zewail, Sherif S. Abdel Mageed, Yasser M. Moustafa, Randa M. Mostafa, Mohamed A. Elkady, Ahmed S. Doghish

Summary: Multiple myeloma is a extensively studied cancer of plasma cells, and researchers are increasingly interested in the role of microRNAs in regulating gene expression in this disease. Non-coding RNAs have been shown to play a crucial role in regulating MM pathogenesis signaling pathways, including Wnt/β-catenin, PI3K/Akt/mTOR, P53, and KRAS. This review emphasizes the importance of miRNAs in MM signaling and their potential as therapeutic targets.

PATHOLOGY RESEARCH AND PRACTICE (2023)

No Data Available